This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Heraeus Precious Metals Gmbh & Co. Kg, Medac Gesellschaft Fur Klinische Spezialpraparate Mbh. Active years: 2014-2016.
Company Filing History:
2 out of 61 
1 out of 17 Years Active: 2014-2016
Title: The Innovations of Stefan Wallert
Introduction
Stefan Wallert is a notable inventor based in Seligenstadt, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable crystalline forms of important compounds. With a total of 3 patents to his name, Wallert's work has the potential to impact medical treatments significantly.
Latest Patents
One of Wallert's latest patents is for crystalline 4'-epidaunorubicin hydrochloride and its use. This invention provides 4'-epidaunorubicin hydrochloride in a crystalline form that is both stable and readily soluble. The process for producing this crystalline form involves crystallizing the compound in a solvent system that includes various solvents, ensuring optimal solubility characteristics. Additionally, a method for producing an anthracycline using this crystalline form is also included in his patent.
Career Highlights
Throughout his career, Wallert has worked with prominent companies in the pharmaceutical industry. Notable among these are Heraeus Precious Metals GmbH & Co. KG and Medac Gesellschaft für Klinische Spezialpräparate mbH. His experience in these organizations has contributed to his expertise in the field and has facilitated his innovative work.
Collaborations
Wallert has collaborated with several professionals in his field, including Sascha Weiser and Andrew Lupton. These collaborations have likely enriched his research and development efforts, leading to successful innovations.
Conclusion
Stefan Wallert's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.